Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
Li
Xiaolin
X
Genomics Institute of the Novartis Research Foundation, Department of Medicinal Chemistry, San Diego, CA 92121, USA.
Yeh
Vince
V
Molteni
Valentina
V
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D002784:Cholesterol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D008024:Ligands; D050155:Lipogenesis / Q000187:drug effects; D000071518:Liver X Receptors; D057093:Orphan Nuclear Receptors / Q000819:agonists*; D010330:Patents as Topic
D008024:Ligands; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; D057093:Orphan Nuclear Receptors; D002784:Cholesterol